Drug recalls

Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, In…

Lupin Pharmaceuticals Inc. · Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.

Class IITerminatedD-0497-2024
Status
Terminated
City
Baltimore
State
MD
Country
United States
Classification
Class II
Product type
Drugs
Event ID
94492
Recalling firm
Lupin Pharmaceuticals Inc.
Address 1
Harborplace Tower
Address 2
111 S Calvert St Fl 21st
Postal code
21202-6174
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
USA nationwide
Recall number
D-0497-2024
Product quantity
17,040 bottles
Reason for recall
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Recall initiation date
20240424
Center classification date
20240514
Termination date
20250429
Report date
20240522
Code info
Lot # F305292, Exp 8/30/2025
Product description

Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-722-04

Harmonized identifiers (openFDA)
Application number
ANDA065259
Brand name
CEFDINIR
Generic name
CEFDINIR
Manufacturer name
Lupin Pharmaceuticals, Inc.
Product NDC
68180-722, 68180-723
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
CEFDINIR
RxCUI
309054, 476576
SPL ID
b32b7bfb-4770-4da0-8c48-684233cd10c9
SPL set ID
7490df67-56c0-4a1c-8533-2107f3e8aea5
Package NDC
68180-722-20, 68180-722-10, 68180-722-04, 68180-722-05, 68180-723-20, 68180-723-10, 68180-723-04, 68180-723-05
Is original packager
true
Upc
0368180723042
Nui
N0000175488, M0003827
Pharm class epc
Cephalosporin Antibacterial [EPC]
Pharm class cs
Cephalosporins [CS]
UNII
CI0FAO63WC
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.